WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark ALLERGAN AESTHETICS was filed as Word mark on 06/30/2020 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1563619 |
| Countries | 
|
| Base trademark |
No. 88821482,
March 4, 2020
|
| Application date | June 30, 2020 |
| Expiration date | June 30, 2030 |
Trademark owner
1 North Waukegan Road, North Chicago, Illinois 60064
US
Trademark representatives
2525 Dupont Drive
Irvine CA 92612
US
goods and services
03
Non-medicated cosmetic and skincare preparations; skin
cleansers; skin toners; facial skin lotions; skin
moisturizers; anti-aging moisturizers; skin creams and
beauty serums; anti-aging creams; eye creams and beauty
serums; anti-wrinkle creams; hair texture cream and hair
texture lotion; firming creams and lotions as cosmetic
preparations; after sun creams; sun damage repair creams;
age-retardant creams as anti-aging cream; age spot reducing
creams; sunscreens as a type of sunscreen preparation;
exfoliant creams; chemical skin peeling solutions as a type
of non-medicated skin care preparation; body mist as
non-medicated skin care preparation; body sprays; facial
mist as non-medicated skin care preparation; facial spray;
beauty masks; non-medicated cosmetics in the form of skin
and face creams, gels, ointments, pastes, foams, lotions,
sprays and waxes for non-medically treating glabellar lines,
facial wrinkles, asymmetries and defects and conditions of
the human skin
05
Pharmaceuticals used in connection with anti-aging, the
treatment of glabellar lines, facial wrinkles, asymmetries
and defects and conditions of the human skin, facial
aesthetic surgery, facial aesthetic reconstruction and
breast aesthetics; topical antibiotics; anti-inflammatory,
anti-infective, anti-glaucoma and decongestant formulations,
namely, anti-inflammatories, anti-infectives, anti-glacuoma
pharmaceutical preparations for the treatment of glaucoma,
and decongestants; pharmaceutical preparations to treat and
prevent glaucoma; ocular wetting solutions, namely, eye
drops, artificial tears and gels as pharmaceutical
preparations for the treatment of minor ocular inflammations
and allergic conditions; pharmaceutical preparations for the
treatment of neurological disorders, muscle dystonias,
smooth muscle disorders, autonomic nerve disorders,
headaches, hyperhydrosis, sports injuries, cerebral palsy,
spasms, tremors and pain; dermatological formulations,
namely, medicated dry skin lotions and creams, acne
medications and medicated skin lighteners; pharmaceutical
preparations for the treatment and prevention of urinary
incontinence and overactive bladder; pharmaceuticals and
medicines for the prevention and treatment of conditions
affecting sensory organs; antibiotics; antifungal
preparations; pharmaceutical preparations for the prevention
and treatment of bacterial infections; pharmaceuticals and
cosmeceuticals, namely, medicated skin cleansers, toners,
serums, moisturizers, rejuvenators, rehydrating creams, and
lotions for the face and body; medicated cosmetic skin care
preparations; pharmaceutical preparations for reducing
localized fat deposits; pharmaceutical preparations, namely,
processed human donor skin for soft tissue regeneration and
reconstruction; processed human donor skin for skin
replacement; biological implants comprised of non-living
processed acellular porcine mesh for the surgical repair and
reinforcement of soft tissues; pharmaceutical preparations
for the treatment of glabellar lines, facial wrinkles,
asymmetries and defects and conditions of the human skin;
biological dermal implants, namely, visco-supplementation
solutions for filling wrinkles
10
Surgical, medical, therapeutic and cosmetic instruments for
treating glabellar lines, facial wrinkles, asymmetries and
defects and conditions of the human skin, and for use in
facial aesthetic surgery, facial aesthetic reconstruction,
breast aesthetics, muscle stimulation, body contouring and
ophthalmic related diseases and disorders; intra-uterine
non-chemical contraceptive devices; medical diagnostic
instruments for the analysis of body fluids; dermatological
microdermabrasion apparatus, namely, instruments used for
performing microdermabrasion of the skin and which deliver
topical solutions to the skin during a procedure; cosmetic
apparatus, namely, an electronic skin treatment device in
the nature of a skin-resurfacing treatment device that
combines exfoliation, extraction, and infusion of
condition-specific serums to improve skin health, function
and appearance; medical devices, namely, apparatus for
tissue cooling, body shaping and contouring, and treatment
of cellulite and soft tissue; medical devices used to
destroy fat cells; medical devices, namely, therapeutic
apparatus and instruments generating high frequency
electromagnetic energy for use in muscle stimulation,
treatment of cellulite and soft tissue, and sculpting,
shaping and contouring of the body; medical devices, namely,
medical apparatus and instruments generating high frequency
electromagnetic energy for use in electrical muscle
stimulation for medical purposes, treatment of cellulite,
and treatment of soft tissue by means of electrical nerve
stimulation for medical purposes; medical devices to
facilitate the placement of cosmetic implants during
surgical procedures; cell transfer apparatus, namely, graft
harvesting instruments; medical injectors, namely, adipose
tissue and medical fluid injectors; surgical and medical
apparatus and instruments for use in processing adipose
tissue; apparatus for the medical treatment of glabellar
lines, facial wrinkles, asymmetries and defects and
conditions of the human skin, namely, needles for the
injection of hyaluronic acid formulations for medical
purposes
35
Advertising services to promote public awareness of medical
aesthetics treatments and procedures through consumer
information programs
41
Educational services, namely, conducting classes and
seminars in the field of medical aesthetics treatments and
procedures
44
Providing medical information to consumers and healthcare
professionals to enhance their understanding of medical
aesthetics treatments and procedures
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| January 7, 2023 | 2023/2 Gaz | PH | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| October 6, 2022 | 2023/4 Gaz | CU | RAW: Second Part Fee Not Paid |
| October 6, 2022 | 2022/42 Gaz | CU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| July 22, 2022 | 2022/31 Gaz | MY | Rejection |
| July 4, 2022 | 2022/27 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| May 30, 2022 | 2022/22 Gaz | KH | Rejection |
| May 5, 2022 | 2022/18 Gaz | TM | Rejection |
| May 5, 2022 | 2022/18 Gaz | MX | Rejection |
| April 26, 2022 | 2022/17 Gaz | TH | Rejection |
| April 12, 2022 | 2022/19 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| April 12, 2022 | 2022/25 Gaz | GE | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| March 28, 2022 | 2022/14 Gaz | CA | Rejection |
| March 28, 2022 | 2022/13 Gaz | IS | Rejection |
| March 14, 2022 | 2022/13 Gaz | MD | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| March 10, 2022 | 2022/11 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| March 7, 2022 | 2022/10 Gaz | LA | Rejection |
| January 1, 2022 | 2022/1 Gaz | KR | Rejection |
| December 28, 2021 | 2022/1 Gaz | TJ | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| December 10, 2021 | 2021/50 Gaz | BA | Rejection |
| December 3, 2021 | 2021/49 Gaz | AM | Rejection |
| November 23, 2021 | 2021/47 Gaz | VN | Rejection |
| November 23, 2021 | 2021/47 Gaz | ME | Rejection |
| November 9, 2021 | 2021/45 Gaz | CH | Rejection |
| November 4, 2021 | 2021/44 Gaz | JP | Rejection |
| October 29, 2021 | 2021/46 Gaz | CU | Rejection |
| October 29, 2021 | 2021/44 Gaz | MD | Rejection |
| October 26, 2021 | 2021/48 Gaz | LI | Rejection |
| October 14, 2021 | 2021/41 Gaz | NO | Rejection |
| September 24, 2021 | 2021/40 Gaz | TJ | Rejection |
| September 14, 2021 | 2021/39 Gaz | GE | Rejection |
| September 14, 2021 | 2021/39 Gaz | GE | Rejection |
| September 10, 2021 | 2021/37 Gaz | ID | Rejection |
| September 9, 2021 | 2021/36 Gaz | UA | Rejection |
| August 17, 2021 | 2021/33 Gaz | BR | Rejection |
| July 30, 2021 | 2021/31 Gaz | KG | Rejection |
| July 14, 2021 | 2021/28 Gaz | CO | Rejection |
| July 9, 2021 | 2021/28 Gaz | KZ | Rejection |
| July 8, 2021 | 2021/28 Gaz | IL | Rejection |
| June 29, 2021 | 2021/26 Gaz | NZ | Rejection |
| June 22, 2021 | 2021/25 Gaz | SM | Rejection |
| June 17, 2021 | 2021/25 Gaz | BY | Rejection |
| June 15, 2021 | 2021/24 Gaz | DZ | Rejection |
| May 24, 2021 | 2021/21 Gaz | RS | Rejection |
| May 17, 2021 | 2021/20 Gaz | IN | Rejection |
| May 7, 2021 | 2021/19 Gaz | MN | Rejection |
| April 22, 2021 | 2021/16 Gaz | EM | Rejection |
| April 14, 2021 | 2021/15 Gaz | GB | Rejection |
| April 6, 2021 | 2021/14 Gaz | CN | Rejection |
| March 31, 2021 | 2021/13 Gaz | TR | Rejection |
| March 19, 2021 | 2021/12 Gaz | AU | Rejection |
| March 1, 2021 | 2021/9 Gaz | RU | Rejection |
| February 3, 2021 | 2021/5 Gaz | MC | Rejection |
| February 3, 2021 | 2021/6 Gaz | SG | Rejection |
| January 25, 2021 | 2021/5 Gaz | PH | Rejection |
| December 3, 2020 | 2021/35 Gaz | HR | Rejection |
| June 30, 2020 | 2020/47 Gaz | US | Registration |
ID: 141563619